Bespoke Extracts (BSPK) Enterprise Value (QoQ) (2011 - 2025)
Bespoke Extracts (BSPK) Enterprise Value (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.60 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.49 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,128.39% |
| Jun 30, 2025 | 95.51% |
| Mar 31, 2025 | 49.65% |
| Dec 31, 2024 | -181.21% |
| Sep 30, 2024 | 13.50% |
| Jun 30, 2024 | -71.97% |
| Mar 31, 2024 | -118.19% |
| Jun 30, 2023 | 55.40% |
| Mar 31, 2023 | 82.13% |
| Dec 31, 2022 | -6.90% |
| Sep 30, 2022 | 37.51% |
| Jun 30, 2022 | 63.71% |
| Nov 30, 2021 | 43.68% |
| Aug 31, 2021 | 86.56% |
| May 31, 2021 | 83.42% |
| Feb 28, 2021 | -94.22% |
| Nov 30, 2020 | -103.98% |
| Aug 31, 2020 | -41,960.80% |
| May 31, 2020 | 99.33% |
| Feb 29, 2020 | 70.16% |